Company / Book Value per Share
Sarepta Therapeutics Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$11.771
FY2025
5-year range
$8.743 / $16.299
FY2021-FY2025
Trend
-27.8%
vs FY2024
Sector context
#50 of 209
Health Care
What the data says
Sarepta Therapeutics's book value per share of $11.771 is higher than 76% of companies in the Health Care sector (FY2025). Book Value per Share has fluctuated over the past 10 years, ranging from $7.379 in FY2016 to $16.299 in FY2024.
Based on SEC 10-K filings.
$11.771 in FY2025 with a 5-year CAGR of -3.0%. Top quartile in the Health Care sector.
Improved from $9.771 to $11.771 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +10.4%
- 5-Year CAGR
- -3.0%
- 10-Year CAGR
- -
Sector benchmark
-93.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -3.0%, indicating a declining trend.
- In FY2025, book value per share decreased 27.8% year-over-year.
- Ranks #50 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.771 | -27.8% |
| FY2024 | $16.299 | +66.8% |
| FY2023 | $9.771 | +11.8% |
| FY2022 | $8.743 | -25.2% |
| FY2021 | $11.692 | -14.8% |
| FY2020 | $13.73 | +23.6% |
| FY2019 | $11.104 | -30.3% |
| FY2018 | $15.932 | +10.5% |
| FY2017 | $14.412 | +95.3% |
| FY2016 | $7.379 | +63.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026